abstract |
A combination drug for treating kidney caner, said combination drug comprising a tyrosine kinase inhibitor combined with a dipeptidyl peptidase 4 inhibitor; and a therapeutic effect enhancer for a tyrosine kinase inhibitor, said therapeutic effect enhancer comprising a dipeptidyl peptidase 4 inhibitor and enhancing the therapeutic effect of the tyrosine kinase inhibitor on kidney cancer. |